APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

3D Printing Pharmaceuticals

3D Printing Pharmaceuticals refers to manufacturing, research or inspection activity in the named process and application category.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Delivered scope, source model, material, process, evidence and acceptance criteria define the work; materials, machines and contracted services must be separated.

What turns activity into demand

Procurement depends on the agreed deliverable, integration, rights and continuing support. Separate initial projects or software access from repeat service work when interpreting the selected market study.

The commercial boundary

Define delivered work, software rights, hardware and continuing services separately. The selected edition describes its research coverage, rather than establishing supplier capabilities.

Which supplied scope and interfaces define 3D Printing Pharmaceuticals?

Delivered scope, source model, material, process, evidence and acceptance criteria define the work; materials, machines and contracted services must be separated.

Selected research

Industry Research

3D Printing Pharmaceuticals Industry Research Report 2026

Report ID 173959010520 December 2025126 pages

Choose your research edition.

Industry Research3D Printing Pharmaceuticals Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal 3D Printing Pharmaceuticals Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal 3D Printing Pharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 3D Printing Pharmaceuticals Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal 3D Printing Pharmaceuticals Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global 3D Printing Pharmaceuticals market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for 3D Printing Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for 3D Printing Pharmaceuticals is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for 3D Printing Pharmaceuticals is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of 3D Printing Pharmaceuticals include Merck KGaA, Merck, AstraZeneca, Triastek,Inc., TNO, Therics, Multiply Labs, FabRx and DiHeSys, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global 3D Printing Pharmaceuticals market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

3D Printing Pharmaceuticals Market by Company

Merck KGaA

Merck

AstraZeneca

Triastek,Inc.

TNO

Therics

Multiply Labs

FabRx

DiHeSys

Aprecia

3D Printing Pharmaceuticals Segment by Type

DPE

SLS

MDD

FDM

MED

DOD

SLA

PB

SSE

3D Printing Pharmaceuticals Segment by Application

Personalized Pharmacy

Nutrients

3D Printing Pharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 3D Printing Pharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 3D Printing Pharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 3D Printing Pharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of 3D Printing Pharmaceuticals manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of 3D Printing Pharmaceuticals by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of 3D Printing Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global 3D Printing Pharmaceuticals Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global 3D Printing Pharmaceuticals Sales (k units) of Manufacturers (2021-2026) Table 7. Global 3D Printing Pharmaceuticals Sales Market Share by Manufacturers (2021-2026) Table 8. Global 3D Printing Pharmaceuticals Revenue of Manufacturers (2021-2026) Table 9. Global 3D Printing Pharmaceuticals Revenue Share by Manufacturers (2021-2026) Table 10. Global Market 3D Printing Pharmaceuticals Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global 3D Printing Pharmaceuticals Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of 3D Printing Pharmaceuticals, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of 3D Printing Pharmaceuticals, Product Type & Application Table 14. Global 3D Printing Pharmaceuticals Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global 3D Printing Pharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Merck KGaA Company Information Table 19. Merck KGaA Business Overview Table 20. Merck KGaA 3D Printing Pharmaceuticals Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Merck KGaA 3D Printing Pharmaceuticals Product Portfolio Table 22. Merck KGaA Recent Developments Table 23. Merck Company Information Table 24. Merck Business Overview Table 25. Merck 3D Printing Pharmaceuticals Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Merck 3D Printing Pharmaceuticals Product Portfolio Table 27. Merck Recent Developments Table 28. AstraZeneca Company Information Table 29. AstraZeneca Business Overview Table 30. AstraZeneca 3D Printing Pharmaceuticals Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. AstraZeneca 3D Printing Pharmaceuticals Product Portfolio Table 32. AstraZeneca Recent Developments Table 33. Triastek,Inc. Company Information Table 34. Triastek,Inc. Business Overview Table 35. Triastek,Inc. 3D Printing Pharmaceuticals Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Triastek,Inc. 3D Printing Pharmaceuticals Product Portfolio Table 37. Triastek,Inc. Recent Developments Table 38. TNO Company Information Table 39. TNO Business Overview Table 40. TNO 3D Printing Pharmaceuticals Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. TNO 3D Printing Pharmaceuticals Product Portfolio Table 42. TNO Recent Developments Table 43. Therics Company Information Table 44. Therics Business Overview Table 45. Therics 3D Printing Pharmaceuticals Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Therics 3D Printing Pharmaceuticals Product Portfolio Table 47. Therics Recent Developments Table 48. Multiply Labs Company Information Table 49. Multiply Labs Business Overview Table 50. Multiply Labs 3D Printing Pharmaceuticals Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Multiply Labs 3D Printing Pharmaceuticals Product Portfolio Table 52. Multiply Labs Recent Developments Table 53. FabRx Company Information Table 54. FabRx Business Overview Table 55. FabRx 3D Printing Pharmaceuticals Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. FabRx 3D Printing Pharmaceuticals Product Portfolio Table 57. FabRx Recent Developments Table 58. DiHeSys Company Information Table 59. DiHeSys Business Overview Table 60. DiHeSys 3D Printing Pharmaceuticals Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. DiHeSys 3D Printing Pharmaceuticals Product Portfolio Table 62. DiHeSys Recent Developments Table 63. Aprecia Company Information Table 64. Aprecia Business Overview Table 65. Aprecia 3D Printing Pharmaceuticals Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Aprecia 3D Printing Pharmaceuticals Product Portfolio Table 67. Aprecia Recent Developments Table 68. Global 3D Printing Pharmaceuticals Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 69. Global 3D Printing Pharmaceuticals Sales by Region (2021-2026) & (k units) Table 70. Global 3D Printing Pharmaceuticals Sales Market Share by Region (2021-2026) Table 71. Global 3D Printing Pharmaceuticals Sales by Region (2027-2032) & (k units) Table 72. Global 3D Printing Pharmaceuticals Sales Market Share by Region (2027-2032) Table 73. Global 3D Printing Pharmaceuticals Revenue by Region (2021-2026) & (US$ Million) Table 74. Global 3D Printing Pharmaceuticals Revenue Market Share by Region (2021-2026) Table 75. Global 3D Printing Pharmaceuticals Revenue by Region (2027-2032) & (US$ Million) Table 76. Global 3D Printing Pharmaceuticals Revenue Market Share by Region (2027-2032) Table 77. North America 3D Printing Pharmaceuticals Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. North America 3D Printing Pharmaceuticals Sales by Country (2021-2026) & (k units) Table 79. North America 3D Printing Pharmaceuticals Sales by Country (2027-2032) & (k units) Table 80. North America 3D Printing Pharmaceuticals Revenue by Country (2021-2026) & (US$ Million) Table 81. North America 3D Printing Pharmaceuticals Revenue by Country (2027-2032) & (US$ Million) Table 82. Europe 3D Printing Pharmaceuticals Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Europe 3D Printing Pharmaceuticals Sales by Country (2021-2026) & (k units) Table 84. Europe 3D Printing Pharmaceuticals Sales by Country (2027-2032) & (k units) Table 85. Europe 3D Printing Pharmaceuticals Revenue by Country (2021-2026) & (US$ Million) Table 86. Europe 3D Printing Pharmaceuticals Revenue by Country (2027-2032) & (US$ Million) Table 87. Asia Pacific 3D Printing Pharmaceuticals Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Asia Pacific 3D Printing Pharmaceuticals Sales by Country (2021-2026) & (k units) Table 89. Asia Pacific 3D Printing Pharmaceuticals Sales by Country (2027-2032) & (k units) Table 90. Asia Pacific 3D Printing Pharmaceuticals Revenue by Country (2021-2026) & (US$ Million) Table 91. Asia Pacific 3D Printing Pharmaceuticals Revenue by Country (2027-2032) & (US$ Million) Table 92. South America 3D Printing Pharmaceuticals Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. South America 3D Printing Pharmaceuticals Sales by Country (2021-2026) & (k units) Table 94. South America 3D Printing Pharmaceuticals Sales by Country (2027-2032) & (k units) Table 95. South America 3D Printing Pharmaceuticals Revenue by Country (2021-2026) & (US$ Million) Table 96. South America 3D Printing Pharmaceuticals Revenue by Country (2027-2032) & (US$ Million) Table 97. Middle East and Africa 3D Printing Pharmaceuticals Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2021-2026) & (k units) Table 99. Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2027-2032) & (k units) Table 100. Middle East and Africa 3D Printing Pharmaceuticals Revenue by Country (2021-2026) & (US$ Million) Table 101. Middle East and Africa 3D Printing Pharmaceuticals Revenue by Country (2027-2032) & (US$ Million) Table 102. Global 3D Printing Pharmaceuticals Sales by Type (2021-2026) & (k units) Table 103. Global 3D Printing Pharmaceuticals Sales by Type (2027-2032) & (k units) Table 104. Global 3D Printing Pharmaceuticals Sales Market Share by Type (2021-2026) Table 105. Global 3D Printing Pharmaceuticals Sales Market Share by Type (2027-2032) Table 106. Global 3D Printing Pharmaceuticals Revenue by Type (2021-2026) & (US$ Million) Table 107. Global 3D Printing Pharmaceuticals Revenue by Type (2027-2032) & (US$ Million) Table 108. Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2021-2026) Table 109. Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2027-2032) Table 110. Global 3D Printing Pharmaceuticals Price by Type (2021-2026) & (US$/unit) Table 111. Global 3D Printing Pharmaceuticals Price by Type (2027-2032) & (US$/unit) Table 112. Global 3D Printing Pharmaceuticals Sales by Application (2021-2026) & (k units) Table 113. Global 3D Printing Pharmaceuticals Sales by Application (2027-2032) & (k units) Table 114. Global 3D Printing Pharmaceuticals Sales Market Share by Application (2021-2026) Table 115. Global 3D Printing Pharmaceuticals Sales Market Share by Application (2027-2032) Table 116. Global 3D Printing Pharmaceuticals Revenue by Application (2021-2026) & (US$ Million) Table 117. Global 3D Printing Pharmaceuticals Revenue by Application (2027-2032) & (US$ Million) Table 118. Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2021-2026) Table 119. Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2027-2032) Table 120. Global 3D Printing Pharmaceuticals Price by Application (2021-2026) & (US$/unit) Table 121. Global 3D Printing Pharmaceuticals Price by Application (2027-2032) & (US$/unit) Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. 3D Printing Pharmaceuticals Distributors List Table 125. 3D Printing Pharmaceuticals Customers List Table 126. 3D Printing Pharmaceuticals Industry Trends Table 127. 3D Printing Pharmaceuticals Industry Drivers Table 128. 3D Printing Pharmaceuticals Industry Restraints Table 129. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. 3D Printing Pharmaceuticals Product Image Figure 5. Global 3D Printing Pharmaceuticals Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global 3D Printing Pharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 7. Global 3D Printing Pharmaceuticals Sales (2021-2032) & (k units) Figure 8. Global 3D Printing Pharmaceuticals Average Price (US$/unit) & (2021-2032) Figure 9. DPE Product Image Figure 10. SLS Product Image Figure 11. MDD Product Image Figure 12. FDM Product Image Figure 13. MED Product Image Figure 14. DOD Product Image Figure 15. SLA Product Image Figure 16. PB Product Image Figure 17. SSE Product Image Figure 18. Personalized Pharmacy Product Image Figure 19. Nutrients Product Image Figure 20. Global 3D Printing Pharmaceuticals Revenue Share by Manufacturers in 2025 Figure 21. Global Manufacturers of 3D Printing Pharmaceuticals, Manufacturing Sites & Headquarters Figure 22. Global Top 5 and 10 3D Printing Pharmaceuticals Players Market Share by Revenue in 2025 Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global 3D Printing Pharmaceuticals Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 25. Global 3D Printing Pharmaceuticals Sales by Region in 2025 Figure 26. Global 3D Printing Pharmaceuticals Revenue by Region in 2025 Figure 27. North America 3D Printing Pharmaceuticals Market Size by Country in 2025 Figure 28. North America 3D Printing Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 29. North America 3D Printing Pharmaceuticals Revenue Market Share by Country (2021-2032) Figure 30. United States 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Canada 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Mexico 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Europe 3D Printing Pharmaceuticals Market Size by Country in 2025 Figure 34. Europe 3D Printing Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 35. Europe 3D Printing Pharmaceuticals Revenue Market Share by Country (2021-2032) Figure 36. Germany 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. France 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. U.K. 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Italy 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Russia 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Spain 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Netherlands 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Switzerland 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Sweden 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Poland 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Asia Pacific 3D Printing Pharmaceuticals Market Size by Country in 2025 Figure 47. Asia Pacific 3D Printing Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 48. Asia Pacific 3D Printing Pharmaceuticals Revenue Market Share by Country (2021-2032) Figure 49. China 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Japan 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South Korea 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. India 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Australia 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Taiwan 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Southeast Asia 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. South America 3D Printing Pharmaceuticals Market Size by Country in 2025 Figure 58. South America 3D Printing Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 59. South America 3D Printing Pharmaceuticals Revenue Market Share by Country (2021-2032) Figure 60. Brazil 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Argentina 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Chile 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Colombia 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Middle East and Africa 3D Printing Pharmaceuticals Market Size by Country in 2025 Figure 65. Middle East and Africa 3D Printing Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 66. Middle East and Africa 3D Printing Pharmaceuticals Revenue Market Share by Country (2021-2032) Figure 67. Egypt 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. South Africa 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. Israel 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Türkiye 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 71. GCC Countries 3D Printing Pharmaceuticals Revenue Growth Rate (2021-2032) & (US$ Million) Figure 72. Global 3D Printing Pharmaceuticals Sales Market Share by Type (2021-2032) Figure 73. Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2021-2032) Figure 74. Global 3D Printing Pharmaceuticals Price (US$/unit) by Type (2021-2032) Figure 75. Global 3D Printing Pharmaceuticals Sales Market Share by Application (2021-2032) Figure 76. Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2021-2032) Figure 77. Global 3D Printing Pharmaceuticals Price (US$/unit) by Application (2021-2032) Figure 78. 3D Printing Pharmaceuticals Value Chain Figure 79. 3D Printing Pharmaceuticals Production Mode & Process Figure 80. Direct Comparison with Distribution Share Figure 81. Distributors Profiles Figure 82. 3D Printing Pharmaceuticals Industry Opportunities and Challenges

Scope & coverage.

Types
  • DPE
  • SLS
  • MDD
  • FDM
  • MED
  • DOD
  • SLA
  • PB
  • SSE
Applications
  • Personalized Pharmacy
  • Nutrients
Companies covered
  • Merck KGaA
  • Merck
  • AstraZeneca
  • Triastek,Inc.
  • TNO
  • Therics
  • Multiply Labs
  • FabRx
  • DiHeSys
  • Aprecia

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global 3D Printing Pharmaceuticals Market Size (2021-2032)
  4. 2.2.2 Global 3D Printing Pharmaceuticals Sales (2021-2032)
  5. 2.2.3 Global 3D Printing Pharmaceuticals Market Average Price (2021-2032)
  6. 2.3 3D Printing Pharmaceuticals by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 DPE
  9. 2.3.3 SLS
  10. 2.3.4 MDD
  11. 2.3.5 FDM
  12. 2.3.6 MED
  13. 2.3.7 DOD
  14. 2.3.8 SLA
  15. 2.3.9 PB
  16. 2.3.10 SSE
  17. 2.4 3D Printing Pharmaceuticals by Application
  18. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  19. 2.4.2 Personalized Pharmacy
  20. 2.4.3 Nutrients
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global 3D Printing Pharmaceuticals Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global 3D Printing Pharmaceuticals Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global 3D Printing Pharmaceuticals Revenue of Manufacturers (2021-2026)
  4. 3.4 Global 3D Printing Pharmaceuticals Average Price by Manufacturers (2021-2026)
  5. 3.5 Global 3D Printing Pharmaceuticals Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of 3D Printing Pharmaceuticals, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of 3D Printing Pharmaceuticals, Product Type & Application
  8. 3.8 Global Manufacturers of 3D Printing Pharmaceuticals, Established Date
  9. 3.9 Global 3D Printing Pharmaceuticals Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Merck KGaA
  2. 4.1.1 Merck KGaA Company Information
  3. 4.1.2 Merck KGaA Business Overview
  4. 4.1.3 Merck KGaA 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Merck KGaA 3D Printing Pharmaceuticals Product Portfolio
  6. 4.1.5 Merck KGaA Recent Developments
  7. 4.2 Merck
  8. 4.2.1 Merck Company Information
  9. 4.2.2 Merck Business Overview
  10. 4.2.3 Merck 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Merck 3D Printing Pharmaceuticals Product Portfolio
  12. 4.2.5 Merck Recent Developments
  13. 4.3 AstraZeneca
  14. 4.3.1 AstraZeneca Company Information
  15. 4.3.2 AstraZeneca Business Overview
  16. 4.3.3 AstraZeneca 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 AstraZeneca 3D Printing Pharmaceuticals Product Portfolio
  18. 4.3.5 AstraZeneca Recent Developments
  19. 4.4 Triastek,Inc.
  20. 4.4.1 Triastek,Inc. Company Information
  21. 4.4.2 Triastek,Inc. Business Overview
  22. 4.4.3 Triastek,Inc. 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Triastek,Inc. 3D Printing Pharmaceuticals Product Portfolio
  24. 4.4.5 Triastek,Inc. Recent Developments
  25. 4.5 TNO
  26. 4.5.1 TNO Company Information
  27. 4.5.2 TNO Business Overview
  28. 4.5.3 TNO 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 TNO 3D Printing Pharmaceuticals Product Portfolio
  30. 4.5.5 TNO Recent Developments
  31. 4.6 Therics
  32. 4.6.1 Therics Company Information
  33. 4.6.2 Therics Business Overview
  34. 4.6.3 Therics 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Therics 3D Printing Pharmaceuticals Product Portfolio
  36. 4.6.5 Therics Recent Developments
  37. 4.7 Multiply Labs
  38. 4.7.1 Multiply Labs Company Information
  39. 4.7.2 Multiply Labs Business Overview
  40. 4.7.3 Multiply Labs 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Multiply Labs 3D Printing Pharmaceuticals Product Portfolio
  42. 4.7.5 Multiply Labs Recent Developments
  43. 4.8 FabRx
  44. 4.8.1 FabRx Company Information
  45. 4.8.2 FabRx Business Overview
  46. 4.8.3 FabRx 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 FabRx 3D Printing Pharmaceuticals Product Portfolio
  48. 4.8.5 FabRx Recent Developments
  49. 4.9 DiHeSys
  50. 4.9.1 DiHeSys Company Information
  51. 4.9.2 DiHeSys Business Overview
  52. 4.9.3 DiHeSys 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 DiHeSys 3D Printing Pharmaceuticals Product Portfolio
  54. 4.9.5 DiHeSys Recent Developments
  55. 4.10 Aprecia
  56. 4.10.1 Aprecia Company Information
  57. 4.10.2 Aprecia Business Overview
  58. 4.10.3 Aprecia 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Aprecia 3D Printing Pharmaceuticals Product Portfolio
  60. 4.10.5 Aprecia Recent Developments
5 Global 3D Printing Pharmaceuticals Market Scenario by Region
  1. 5.1 Global 3D Printing Pharmaceuticals Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global 3D Printing Pharmaceuticals Sales by Region: 2021-2032
  3. 5.2.1 Global 3D Printing Pharmaceuticals Sales by Region: 2021-2026
  4. 5.2.2 Global 3D Printing Pharmaceuticals Sales by Region: 2027-2032
  5. 5.3 Global 3D Printing Pharmaceuticals Revenue by Region: 2021-2032
  6. 5.3.1 Global 3D Printing Pharmaceuticals Revenue by Region: 2021-2026
  7. 5.3.2 Global 3D Printing Pharmaceuticals Revenue by Region: 2027-2032
  8. 5.4 North America 3D Printing Pharmaceuticals Market Facts & Figures by Country
  9. 5.4.1 North America 3D Printing Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America 3D Printing Pharmaceuticals Sales by Country (2021-2032)
  11. 5.4.3 North America 3D Printing Pharmaceuticals Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe 3D Printing Pharmaceuticals Market Facts & Figures by Country
  16. 5.5.1 Europe 3D Printing Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe 3D Printing Pharmaceuticals Sales by Country (2021-2032)
  18. 5.5.3 Europe 3D Printing Pharmaceuticals Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific 3D Printing Pharmaceuticals Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific 3D Printing Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific 3D Printing Pharmaceuticals Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific 3D Printing Pharmaceuticals Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America 3D Printing Pharmaceuticals Market Facts & Figures by Country
  41. 5.7.1 South America 3D Printing Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America 3D Printing Pharmaceuticals Sales by Country (2021-2032)
  43. 5.7.3 South America 3D Printing Pharmaceuticals Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa 3D Printing Pharmaceuticals Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa 3D Printing Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa 3D Printing Pharmaceuticals Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global 3D Printing Pharmaceuticals Sales by Type (2021-2032)
  2. 6.1.1 Global 3D Printing Pharmaceuticals Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global 3D Printing Pharmaceuticals Sales Market Share by Type (2021-2032)
  4. 6.2 Global 3D Printing Pharmaceuticals Revenue by Type (2021-2032)
  5. 6.2.1 Global 3D Printing Pharmaceuticals Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2021-2032)
  7. 6.3 Global 3D Printing Pharmaceuticals Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global 3D Printing Pharmaceuticals Sales by Application (2021-2032)
  2. 7.1.1 Global 3D Printing Pharmaceuticals Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global 3D Printing Pharmaceuticals Sales Market Share by Application (2021-2032)
  4. 7.2 Global 3D Printing Pharmaceuticals Revenue by Application (2021-2032)
  5. 7.2.1 Global 3D Printing Pharmaceuticals Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2021-2032)
  7. 7.3 Global 3D Printing Pharmaceuticals Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 3D Printing Pharmaceuticals Value Chain Analysis
  2. 8.1.1 3D Printing Pharmaceuticals Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 3D Printing Pharmaceuticals Production Mode & Process
  5. 8.2 3D Printing Pharmaceuticals Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 3D Printing Pharmaceuticals Distributors
  8. 8.2.3 3D Printing Pharmaceuticals Customers
9 Global 3D Printing Pharmaceuticals Analyzing Market Dynamics
  1. 9.1 3D Printing Pharmaceuticals Industry Trends
  2. 9.2 3D Printing Pharmaceuticals Industry Drivers
  3. 9.3 3D Printing Pharmaceuticals Industry Opportunities and Challenges
  4. 9.4 3D Printing Pharmaceuticals Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst